Johnson & Johnson Cv Rx, Inc. Call Options Transaction History
Johnson & Johnson
- $293 Million
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CVRX
# of Institutions
95Shares Held
15.7MCall Options Held
67KPut Options Held
26.9K-
Nea Management Company, LLC Timonium, MD2.03MShares$29.8 Million1.83% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT921KShares$13.6 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA910KShares$13.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$12.9 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY628KShares$9.25 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $303M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...